WO2024184702 - VH4-34 ANTIGEN-BINDING MOLECULES
National phase entry:
Publication Number
WO/2024/184702
Publication Date
12.09.2024
International Application No.
PCT/IB2024/000118
International Filing Date
08.03.2024
Title **
[English]
VH4-34 ANTIGEN-BINDING MOLECULES
[French]
MOLÉCULES DE LIAISON À L'ANTIGÈNE VH4-34
Applicants **
HUMMINGBIRD BIOSCIENCE PTE. LTD.
Inventors
PALIWAL, Shalini
THAKKAR, Dipti
CHIN, Wen, Jie
LEE, Warren
NEO, Jacklyn, Jie Ying
HANSON, Brendon
PASZKIEWICZ, Konrad
INGRAM, Piers
BOYD-KIRKUP, Jerome
SIM, Adelene
Priority Data
63/451,053
09.03.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3987 | |
| EPO | Filing, Examination, Granting | 25238 | |
| Japan | Filing, Examination, Granting | 2932 | |
| South Korea | Filing, Examination, Granting | 3459 | |
| USA | Filing, Examination, Granting | 10640 |
Total:
46,256
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Provided herein are VH4-34 antigen binding molecules (e.g., VH4-34 antibodies). compositions comprising the same, and methods of use.[French]
L'invention concerne des molécules de liaison à l'antigène VH4-34 (par exemple, des anticorps VH4-34). L'invention concerne également des compositions les comprenant, et des procédés d'utilisation.